NCT01290159

Brief Summary

Today, the level of tolerance to heat is based on physiological strain indices, with no correlates to any relevant biomarker. We hypothesize that oxidative stress (OS) and the formation of reactive oxygen and nitrogen species (ROS, RNS), which are part of the underling pathophysiology related to hyperthermia, can be used to identify tolerance/intolerance to heat. The aim of the present project is to develop a simple assay, based on specific designed sensitive biomarkers of OS that can be detected in a small blood sample, and to possibly correlate each individual's state of tolerance to heat to the level of OS. These biomarkers specially designed and synthesized to form a novel probe (not present as such in biological organs). The method will be based on the incubation of the suggested biomarkers with the patient's blood sample and the measurement of the level and type of oxidative alteration of the markers. For this goal, post heat stroke patients, with different levels of tolerance to heat and subjects during a process of acclimation to heat will be studied. Such a method will add to our ability to better determine the level of tolerance to heat and not rely only on the measurements of temperature and heart rate during an exercise-heat stress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 4, 2011

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

December 19, 2013

Status Verified

December 1, 2013

Enrollment Period

1.9 years

First QC Date

February 3, 2011

Last Update Submit

December 18, 2013

Conditions

Keywords

tolerance to heat

Study Arms (3)

post heat stroke heat tolerant

Other: heat tolerance test (HTT)

post heat stroke heat intolerant

Other: heat tolerance test (HTT)

healthy controls

Other: heat tolerance test (HTT)

Interventions

An exercise-heat test,which consists of 120 min exposure to walking on a treadmill (5km/h; 2% grade) under conditions of 40oC and 50% rh.

Also known as: heat strain
healthy controlspost heat stroke heat intolerantpost heat stroke heat tolerant

Eligibility Criteria

Age18 Years - 28 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

young (18-28 years old) post heat stroke subjects, and matched healthy controls

You may qualify if:

  • for study group: post heat stroke subjects. for control group: healthy subjects matched by age to study group

You may not qualify if:

  • for control group: any prior heat illness, Diabetes, heart failure, high blood pressure (SBP \>140mmHg), any febrile illness within the last two weeks prior to testing.
  • for study group: Diabetes, heart failure, high blood pressure (SBP \>140mmHg), any febrile illness within the last two weeks prior to testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heller Institute of Medical Research, Sheba Medical Center

Tel Litwinsky, 52621, Israel

Location

MeSH Terms

Conditions

Heat Stroke

Condition Hierarchy (Ancestors)

Heat Stress DisordersWounds and Injuries

Study Officials

  • Yoram Epstein, PhD

    Heller Institute of Medical Research, Sheba Medical Center, Tel Hashomer

    STUDY DIRECTOR
  • Amit Druyan, MD

    Heller Institute of Medical Research, Sheba Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Heller institue, Sheba Medical Center

Study Record Dates

First Submitted

February 3, 2011

First Posted

February 4, 2011

Study Start

May 1, 2011

Primary Completion

April 1, 2013

Study Completion

July 1, 2013

Last Updated

December 19, 2013

Record last verified: 2013-12

Locations